The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Conflicting data aside, contraception experts agree that ulipristal acetate, or ella, is a more effective option for people ...

Patients who took a single high dose of GUBamy lost 3% of their body weight during the 6-week trial, while those on a placebo ...

Presented New CRB-913 Pre-Clinical Data at Obesity Week 2024 - Phase 1 Trial Expected to Commence in Q1 2025 ...

Novo Nordisk (NVO) announced Friday a pivotal Phase 3 trial designed to test its weight loss therapy semaglutide on patients with a liver disease called metabolic dysfunction-associated ...

NordVPN's free trial lets you play with a ton of features without spending a fortune. You'll get tough encryption that'll protect your personal data – and NordVPN is more than fast enough to ...

Oxford Medical Products has revealed positive topline results from the first randomised controlled trial ... weight maintenance market, to help patients transitioning off GLP-1s avoid weight re ...

4. Sitting Too Much Sitting for long periods may be the reason for weight gain or a lack of weight loss. Research has found that your risk for obesity increases by 5% for every two hours of sitting.